- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anhui Anke BioTech Group (300009)
Anhui Anke BioTech Group stock price live, this page displays SZ 300009 stock exchange data. View the 300009 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Anhui Anke BioTech Group real time stock price chart below.
What Is the Anhui Anke BioTech Group Stock Price Today?
The Anhui Anke BioTech Group stock price today is 8.95.
What Is the Stock Symbol for Anhui Anke BioTech Group?
The stock symbol for Anhui Anke BioTech Group is "300009."
What Stock Exchange Does Anhui Anke BioTech Group Trade On?
Anhui Anke BioTech Group is listed and trades on the Shenzhen stock exchange.
Is Anhui Anke BioTech Group a Good Stock to Buy?
Determining whether Anhui Anke BioTech Group—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300009 quote. (ISIN: CNE100000GY2)
What Is the Anhui Anke BioTech Group Stock Price Today?
The Anhui Anke BioTech Group stock price today is 8.95.
What Is the Stock Symbol for Anhui Anke BioTech Group?
The stock symbol for Anhui Anke BioTech Group is "300009."
What Stock Exchange Does Anhui Anke BioTech Group Trade On?
Anhui Anke BioTech Group is listed and trades on the Shenzhen stock exchange.
Is Anhui Anke BioTech Group a Good Stock to Buy?
Determining whether Anhui Anke BioTech Group—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300009 quote. (ISIN: CNE100000GY2)
Shenzhen
Currency in CNY
8.95
+0.17(+1.94%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.71
9.18
52 wk Range
7.35
12.51
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.719.18
52 wk Range
7.3512.51
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.85%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.85%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300009 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Apr 23, 2026
EPS / Forecast
0.10 / --
Revenue / Forecast
541.72M / --
Compare 300009 to Peers and Sector
Metrics to compare | 300009 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300009PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.5x | 48.4x | −0.4x | |
PEG Ratio | 10.36 | 0.10 | 0.00 | |
Price/Book | 3.1x | 2.6x | 2.6x | |
Price / LTM Sales | 5.8x | 6.5x | 3.1x | |
Upside (Analyst Target) | - | 30.6% | 48.3% | |
Fair Value Upside | Unlock | 5.2% | 6.2% | Unlock |
Anhui Anke Biotechnology (Group) Co., Ltd. engages in the biopharmaceutical industry in China and internationally. It offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. The company provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, immunohistochemical, sperm DNA fragmentation staining, leptin, and immunohistochemical diagnostic kits. In addition, it offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care products, including anti-aging, masks, essential liquids, and mouthwash; and sybthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, the company provides autosomal, sex chromosome, and other kits; paternity testing, tumor biological immunotherapy technology, and DNA testing services. Additionally, the company offers monoclonal antibody drugs, such as Trastuzumab to treat patients with breast and gastric cancers under the ANTRASTUIN brand; Bevacizumab, an anti-VFDF product; ANKEBIO anti-PD1; and anti-covid19 products. The company was founded in 2000 and is based in Hefei, China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Anhui Anke BioTech Group (300009) Stock Price Today?
The Anhui Anke BioTech Group stock price today is 8.95 CNY.
What Stock Exchange Does Anhui Anke BioTech Group Trade On?
Anhui Anke BioTech Group is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Anhui Anke BioTech Group?
The stock symbol for Anhui Anke BioTech Group is "300009."
Does Anhui Anke BioTech Group Pay Dividends? What’s The Current Dividend Yield?
The Anhui Anke BioTech Group dividend yield is 2.85%.
What Is the Anhui Anke BioTech Group Market Cap?
As of today, Anhui Anke BioTech Group market cap is 14.92B CNY.
What Is Anhui Anke BioTech Group's Earnings Per Share (TTM)?
The Anhui Anke BioTech Group EPS (TTM) is 0.42.
When Is the Next Anhui Anke BioTech Group Earnings Date?
Anhui Anke BioTech Group will release its next earnings report on Aug 26, 2026.
From a Technical Analysis Perspective, Is 300009 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Anhui Anke BioTech Group Stock Split?
Anhui Anke BioTech Group has split 10 times.
How Many Employees Does Anhui Anke BioTech Group Have?
Anhui Anke BioTech Group has 2505 employees.
What is the current trading status of Anhui Anke BioTech Group (300009)?
As of Aug 16, 2026, Anhui Anke BioTech Group (300009) is trading at a price of 8.95 CNY, with a previous close of 8.78 CNY. The stock has fluctuated within a day range of 8.71 CNY to 9.18 CNY, while its 52-week range spans from 7.35 CNY to 12.51 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.